SevereStreptococcus pyogenesInfections, United Kingdom, 2003–2004
Open Access
- 1 February 2008
- journal article
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 14 (2), 202-209
- https://doi.org/10.3201/eid1402.070888
Abstract
As part of a Europe-wide initiative to explore current epidemiologic patterns of severe disease caused by Streptococcus pyogenes, the United Kingdom undertook enhanced population-based surveillance during 2003–2004. A total of 3,775 confirmed cases of severe S. pyogenes infection were identified over 2 years, 3.33/100,000 population, substantially more than previously estimated. Skin/soft tissue infections were the most common manifestation (42%), followed by respiratory tract infections (17%). Injection drug use was identified as a risk factor for 20% of case-patients. One in 5 infected case-patients died within 7 days of diagnosis; the highest mortality rate was for cases of necrotizing fasciitis (34%). Nonsteroidal antiinflammatory drugs, alcoholism, young age, and infection with emm/M3 types were independently associated with increased risk for streptococcal toxic shock syndrome. Understanding the pattern of these diseases and predictors of poor patient outcome will help with identification and assessment of the potential effect of targeted interventions.Keywords
This publication has 24 references indexed in Scilit:
- O266 Risk factors for invasive group A streptococcal infections in EuropeInternational Journal of Antimicrobial Agents, 2007
- Population-based surveillance of invasive pyogenic streptococcal infection in a large Canadian regionClinical Microbiology & Infection, 2006
- Characterization of group A streptococci (Streptococcus pyogenes): correlation of M-protein and emm-gene type with T-protein agglutination pattern and serum opacity factorJournal of Medical Microbiology, 2006
- Invasive group A, B, C and G streptococcal infections in Denmark 1999–2002: epidemiological and clinical aspectsClinical Microbiology & Infection, 2005
- Variations inemmType among Group A Streptococcal Isolates Causing Invasive or Noninvasive Infections in a Nationwide StudyJournal of Clinical Microbiology, 2005
- Invasive Group A Streptococcal Disease in Alberta, Canada (2000 to 2002)Journal of Clinical Microbiology, 2005
- Group A Streptococcal Infections in Sweden: A Comparative Study of Invasive and Noninvasive Infections and Analysis of Dominant T28 emm28 IsolatesClinical Infectious Diseases, 2003
- Increasing incidence of group A streptococcal infections amongst injecting drug users in England and WalesJournal of Medical Microbiology, 2003
- Epidemiology of Invasive Group AStreptococcusDisease in the United States, 1995–1999Clinical Infectious Diseases, 2002
- Invasive Group A Streptococcal Infections in Sweden in 1994 and 1995: Epidemiology and Clinical SpectrumScandinavian Journal of Infectious Diseases, 2000